+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-06-18Number of Pages: 94

Aptamers Market (Type - Nucleic Acid Aptamers and Peptide Aptamers; Application - Therapeutics Development, Diagnostics, and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Aptamers Market: Snapshot 

Aptamers offer immense potential for the development of unique applications in the field of fundamental research, drug selection, clinical diagnosis, and therapies. They have gained worldwide preference over antibodies owing to the former’s key benefits – greater binding affinity, high specificity, and the ability to not destroy neighboring cells. The major factors driving the aptamers market is growing interest of research scientists in the field of aptamer technology and increasing support from private organizations. On the flip side, lack of knowledge about this technology results in low acceptance. Moreover, ethical issues and inadequate regulatory policies related to aptamer technology threaten to impede the growth of this market. 

The worldwide market for aptamers is slated to exhibit an impressive CAGR of 73.1% during the course of the forecast period, rising to a value of US$4.3 bn by 2019. 

Growing Application of Aptamers in Therapeutics 

Accounting for the leading share by type, nucleic acid aptamers are anticipated to present an opportunity worth US$3.3 bn by 2019, developing at an astounding CAGR of 73.4% during the forecast period. Nucleic acid aptamers have been gaining much traction as a substitute for protein-based targeting approaches. This segment is also projected to be driven by a rising number of leading players collaborating with various organizations and research institutes in order to develop customized nucleic acid aptamers. The introduction of novel selection processes and advanced technology-based aptamers. 

On the basis of application, therapeutics is slated to enjoy the dominant share in the aptamers market, registering a strong CAGR of 80.3% during the forecast period to amount to an estimated US$1.4 bn by 2019. The use of aptamers has revolutionized the field of therapeutic development and a number of companies are working toward developing different aptamers for the treatment of a variety of diseases. This is a key factor boosting the uptake of aptamers in therapeutics. Other applications of aptamers include diagnostics and research. 

Consistent Collaborations and Investments in R&D to Lend Asia Pacific a Helping Hand 

The global market for aptamers is segmented on the basis of geography into Europe, North America, Asia Pacific, and Rest of the World. At the start of the forecast period, North America accounted for more than two-fifth of the overall aptamers market, driven by the strong presence of established companies and growing investments made by them in the field. Europe followed suit, powered by the rising usage of aptamer technologies by small-scale industries. Growth of the aptamers market in this region can also be attributed to consistent efforts and collaborations by players in order to enter the market. 

Asia Pacific is projected to witness strong growth by 2019 thanks to impressive investments in R&D, backed by encouraging policies by various governments for the expansion of the pharmaceutical sector. The growing incidence of chronic disorders, such as Alzheimer’s and HIV/AIDS, in APAC has upped the demand for novel therapeutics, which in turn drives the demand for aptamers. Brimming with opportunities in pharmaceutical and diagnostics, the aptamers market in Asia Pacific is sure to attract a lot of attention in the years to come as key players continue to expand and increase product distribution in China, India, and other lucrative countries. 

Some of the prominent companies competing in the global aptamers market are Base Pair Biotechnologies, Inc., Vivonics, Inc., SomaLogic Inc., Aptagen, LLC, Aptus Biotech S.L., NeoVentures Biotechnology, Aptamer Solutions Ltd, TriLink BioTechnologies, Inc., AM Biotechnologies, LLC, and Aptamer Sciences, Inc. There is a high degree of rivalry among the key players and this has brought about a surge in investments for the development of novel aptamers.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research
               1.3.1.3 Assumptions
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Aptamers Market (2012 & 2019)
      2.1.1 Global Aptamers Market by Types, 2012 (USD Million)
2.2 Comparative Analysis: Global Aptamers Market, By Geography, 2012 and 2019 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis
3.3 Market Dynamics
      3.3.1 Market Drivers
               3.3.1.1 Increasing interest of research scientists in the field of aptamer technology owing to various advantages over antibodies
               3.3.1.2 Rising support and participation of private organizations aiming to increase advancements in aptamer field
      3.3.2 Market Restraints
               3.3.2.1 Inadequate regulatory policies and ethical issues related to aptamer development
               3.3.2.2 Lack of knowledge and unfavorable characteristics of aptamers will lead low acceptance
      3.3.3 Market Opportunities
               3.3.3.1 Modification in aptamer chemistry will offer high acceptance
3.4 Porter’s Five Force Analysis
      3.4.1 Bargaining power of suppliers – Low - Medium
      3.4.2 Bargaining power of buyers – Low - Medium
      3.4.3 Threat of substitutes – High – Medium
      3.4.4 Threat of new entrants – Medium - High
      3.4.5 Competitive rivalry – Low - Medium
3.5 Market Attractiveness Analysis: Global Aptamers Market, by Geography
 
Chapter 4 Aptamers Market, by Types
4.1 Introduction
      4.1.1 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
4.2 Nucleic Acid Aptamers
      4.2.1 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million)
4.3 Peptide Aptamers
      4.3.1 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 5 Aptamers Market, by Applications
5.1 Overview
      5.1.1 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Therapeutics Development
      5.2.1 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million)
5.3 Diagnostics (Molecular Imaging, Biomarker Detection and Discovery)
      5.3.1 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
5.4 Research and Development Applications (Targeted Drug Delivery, Drug Discovery and Development)
      5.4.1 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million)
5.5 Others (Biosensor and Food Safety)
      5.5.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 6 Aptamers Market, by Geography
6.1 Overview
      6.1.1 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 7 Competitive Landscape
7.1 Market Share by Key Players of Global Aptamers Market, 2012 (%)
      7.1.1 Global Aptamers Market Share Analysis, by Key Players, 2012 (%)
 
Chapter 8 Recommendations
8.1 Market Strategy for Success
      8.1.1 Focus on emerging aptamer selection technologies that improves aptamer affinity and specificity
      8.1.2 Focus on investing in research and development activities
 
Chapter 9 Company Profiles
9.1 AM Biotechnologies, LLC
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Aptagen, LLC
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Aptamer group
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies 
      9.3.5 Recent Developments
9.4 Aptamer Sciences, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies 
      9.4.5 Recent Developments
9.5 Base Pair Biotechnologies, Inc.
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies 
      9.5.5 Recent Developments
9.6 Bioapter S.L.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies 
9.7 CD Genomics
      9.7.1 Company Overviews
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies 
9.8 Neo Ventures Biotechnology, Inc.
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies 
      9.8.5 Recent Developments
9.9 NOXXON Pharma AG
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies 
      9.9.5 Recent Developments
9.10 Optech Biotech
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies 
      9.10.5 Recent Developments
9.11 Ophthotech Corporation
      9.11.1 Company Overview
      9.11.2 Product Portfolio
      9.11.3 Business Strategies 
9.12 Regado Biosciences, Inc.
      9.12.1 Company Overview
      9.12.2 Financial Overview
      9.12.3 Product Portfolio
      9.12.4 Business Strategies 
      9.12.5 Recent Developments
9.13 Somalogic, Inc.
      9.13.1 Company Overview
      9.13.2 Financial Overview
      9.13.3 Product Portfolio
      9.13.4 Business Strategies 
      9.13.5 Recent Developments
9.14 TriLink Biotechnologies, Inc.
      9.14.1 Company Overview
      9.14.2 Financial Overview
      9.14.3 Product Portfolio
      9.14.4 Business Strategies 
      9.14.5 Recent Developments
9.15 Vivonics, Inc.
      9.15.1 Company Overview
      9.15.2 Financial Overview
      9.15.3 Product Portfolio
      9.15.4 Business Strategies
      9.15.5 Recent Developments

List of Figures
 
FIG. 1 Aptamers Market Segmentation
FIG. 2 Global Aptamers Market, by Types, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Aptamers Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Aptamers Market
FIG. 5 Market Attractiveness Analysis: Global Aptamers Market, by Geography, 2012 Value (%)
FIG. 6 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 North America Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Aptamers Market: Market Share, by Key Players, 2012 (%)

List of Table
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Aptamers Market (2012 & 2019)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)

Aptamers are single standard oligonucleotides that exhibit high specificity and affinity to the variety of target molecules like proteins, bacteria or whole cell. Advancement in aptamer selection technologies which enables to generate high quality of aptamers coupled with efforts of key manufacturer to develop novel aptamers for diagnostics and therapeutics purpose will drive the market growth of global aptamers market. Aptamers technology also plays an important role in the field of biomarker discovery, drug development, analytical chemistry and others. The aptamers market is witnessing tremendous growth worldwide mainly due to various advantages over antibodies such as ease of synthesis and modification, ability to develop improved and cost-effective drugs. In addition, increasing number of scientific research on aptamers further propel the market growth. However, lack of knowledge coupled with ethical hurdles will restrain the market growth of global aptamers market. 
 
The market for aptamers is segmented into by types and by applications. Types segment includes nucleic aptamers and peptide aptamers. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.
 
Aptamers market, by application segment divided into therapeutics development, diagnostics, research and development application and others. This report covers participation of different organizations of the U.S., the U.K. for the development of aptamer field. In addition, it explains various technological advancement and consistent efforts by key players to develop novel aptamers for therapeutic applications. The report includes market estimations of the global aptamers market in terms of value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global aptamers market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.
 
The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global aptamers market and future opportunities are provided in the aptamers market report. The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global aptamers market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.
 
Some of the key market players of the global aptamers market include Aptagen, Inc., Aptamer group, Aptamer Sciences, Inc., Somalogic, Inc., “NOXXON Pharma AG,.” and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
 
The global aptamers market is segmented into the following categories:
  • Aptamers Market, by Types
    • Nucleic Acid Aptamers
    • Peptide Aptamers
  • Aptamers Market, by Applications
    • Therapeutics Development
    • Diagnostics
    • Research and Development Application
    • Others
  • Aptamers Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of World (RoW)


 
 
Back To Top